[sci.med] HICN226 News Part 3/3

ATW1H%ASUACAD.BITNET@oac.ucla.edu (Dr David Dodell) (06/28/89)

--- begin part 3 of 3 cut here ---
from   sexually   transmitted   disease   (STD)   clinics  indicate  that  HIV
seroprevalence is highest among IVDUs and their sex partners.  In  an  ongoing
study  begun in January 1988 of New York City STD clinic clients who consented
to be interviewed and tested for HIV,  63 (47%) of 134 IVDUs and 25  (13%)  of
193  persons  with  a sex partner who used IV drugs were HIV-positive (4).  In
addition,  a 1987 survey of STD clinic attendees  in  Baltimore  detected  HIV
antibody  in  34  (15%) of 224 men and 14 (22%) of 65 women with self-reported
histories of IV-drug use and 18 (11%) of 170 women who reported sexual contact
with men who were bisexual or used IV drugs (5). Among clinic patients who did
not report any risks for HIV infection, including male homosexual contact, IV-
drug  use,   or  sexual  contact  with  a  partner  at  increased  risk,   HIV
seroprevalence was 4% (20/571) in men and 5% (9/196) in women in New York City
(4),  3% (56/2068) in men and 2% (20/1115) in women in Baltimore (5), and 0.2%
(4/1634) in men and 0 (0/940) in women in Denver (6).
    HIV transmission among heterosexually active persons without  known  risks
in  either partner also can be monitored by interviewing seropositive civilian
recruit applicants for military service and blood donors.  HIV  seropositivity
lower  than  that  in  comparable  segments of the general population would be
expected because both groups are screened to exclude persons with histories of
male homosexual contact,  IV-drug use,  or  hemophilia.  Seropositive  recruit
applicants  and  blood  donors  therefore  might  be  expected  to  include  a
relatively large proportion  of  persons  with  HIV  infection  acquired  from
heterosexual partners who were not suspected or known to be infected.
    Among  approximately  1.5 million male and 253,547 female civilian recruit
applicants screened during  October  1985-September  1988,  0.15%  and  0.07%,
respectively,  were  HIV  seropositive  (2).  In  limited follow-up studies of
seropositive male recruit applicants,  most had risk factors for HIV infection
other than heterosexual contact.  In New York City and Denver,  19 (86%) of 22
and 10 (91%) of 11 seropositive male applicants,  respectively,  admitted male
homosexual  contact  or  IV-drug use;  the remaining four men reported contact
with a female prostitute (7,8).  Too few seropositive women were available for
analysis.
    Among  1.3  million  male  and  1.2 million female first-time blood donors
tested during April 1985-September 1988, 0.067% and 0.014%, respectively, were
HIV-seropositive (2).  In an ongoing follow-up  study  of  seropositive  blood

Health InfoCom Network News                                             Page 20
Volume  2, Number 26                                            June 26, 1989

donors  in  16  cities,  50%  of  interviewed  donors reported male homosexual
contact or IV-drug use;  18 (8%) of 228 interviewed seropositive males and  43
(57%) of 76 women reported heterosexual contact with a partner at risk for HIV
infection; women were more likely than men (36% and 29%, respectively) to have
no risk identified (9).

Reported by:  Local, state, and territorial health departments.  AIDS Program,
Center for Infectious Diseases, CDC.

Editorial Note: In general, a person's risk of acquiring HIV infection through
sexual contact depends  on  1)  the  number  of  different  partners,  2)  the
likelihood  (prevalence)  of  HIV  infection  in  these  partners,  and 3) the
probability of virus transmission  during  sexual  contact  with  an  infected
partner  (10).  Virus  transmission,  in  turn,  may  be  affected by biologic
factors,  such as concurrent STD infections in either partner  (e.g.,  genital
ulcer  disease);  behavioral factors,  such as type of sex practice and use of
condoms;  or varying levels of infectivity in the source  partner  related  to
clinical  stage  of  disease  (11).  Based on these factors,  the risk for HIV
infection is highest for a regular partner of an HIV-infected person.  Persons
who  have  sex  partners with risk factors for HIV infection or who themselves
have multiple partners from urban settings with  high  rates  of  IV-drug  and
"crack" cocaine use (4,12), prostitution, and other STDs are also at increased
risk.
    Surveillance  data  for heterosexual transmission of HIV infection need to
be interpreted cautiously.  The actual number of AIDS  cases  reported  to  be
associated  with heterosexual transmission probably underestimates the role of
this mode of spread.  Nearly 3000 persons classified as bisexual men and IVDUs
and  persons  with hemophilia also reported heterosexual contact with a person
at risk.  Therefore,  some of these persons  may  have  acquired  HIV  through
heterosexual contact rather than through these other routes.  Similarly,  some
persons  with  an  undetermined  risk  may  have   become   infected   through
heterosexual  contact.  Persons  with an undetermined risk are demographically
similar to AIDS patients who report IV-drug  use  or  sexual  contact  with  a
partner  at  risk.  Nearly 40% of persons with an undetermined risk have self-
reported histories of an STD,  and one third of men  reported  sexual  contact
with a female prostitute (13).  Conversely,  some persons with AIDS attributed
to heterosexual transmission may have  other  unacknowledged  or  undetermined
risk factors.  For example,  inconsistencies in the geographic distribution of
men who reported sexual contact with a female IVDU, as well as the tendency of
men to have partners with an unknown risk, suggests that some of these men may
be misclassified.  Underascertainment of heterosexual transmission  among  men
probably exists in other areas.
    Compared  with AIDS case data,  seroprevalence surveys reflect more recent
patterns of HIV infection.  However,  only limited information  regarding  the
spread  of  heterosexually  acquired  HIV  infection is available from current
surveys  because  relatively  few  collect  information  about  risk  factors.
Additional  follow-up  studies  of  STD  clinic  patients,  seropositive blood
donors, and civilian recruit applicants are now under way or being implemented
to aid in monitoring the level and trends of heterosexual transmission (14).
    Both AIDS surveillance and HIV seroprevalence follow-up  studies  indicate
that  an  appreciable  proportion  of  HIV infection among women in the United
States is acquired through heterosexual contact. Because HIV seroprevalence is
greater in men,  a woman is more  likely  than  a  man  to  have  an  infected
heterosexual  partner.  Women  may  also be unaware of the infection status of
their male partners, as suggested by data on civilian recruit applicants.  HIV

Health InfoCom Network News                                             Page 21
Volume  2, Number 26                                            June 26, 1989

seroprevalence  rates  among male recruit applicants have declined since 1985;
in contrast,  rates among female applicants have remained  stable,  suggesting
that  women  may  be  less  likely  to  self-defer because they do not know or
suspect they are infected (2). The predominance of heterosexually acquired HIV
infections in  women  of  reproductive  age  has  important  implications  for
perinatal HIV transmission;  nearly 30% of children with AIDS were infected by
their mothers who acquired infection through heterosexual contact.
    Recent increases  in  syphilis  among  heterosexuals,  particularly  among
prostitutes,  drug users, and their sexual contacts (15,16), indicate the need
for more intensive application of recommended measures  (17,18)  to  interrupt
sexual  and  drug-use-  related transmission of HIV infection.  These measures
include:  --development  of  community  health  education  programs  aimed  at
populations   at   increased  risk;   !participation  in  mutually  monogamous
relationships or reduction of the number of sex partners;  --use of condoms to
prevent exposure to semen and infected lymphocytes; --enrollment of drug users
in  programs  to  eliminate  use  of  IV-drugs;  and --increased voluntary HIV
testing and counseling of persons at increased risk in settings  such  as  STD
and family planning clinics and drug-treatment programs.

References

 1. CDC. Human immunodeficiency virus infection in the United States: a review
of  current  knowledge.  MMWR  1987;36(suppl  S-6).

 2.  CDC.  AIDS and human  immunodeficiency  virus  infection  in  the  United
States: 1988 update.  MMWR 1989:38(suppl S-4).

 3.  Darrow WW, Bigler W, Deppe D, et al. HIV antibody in 640 U.S. prostitutes
with no evidence of intravenous (IV)-drug abuse (Abstract).  IV  International
Conference on AIDS. Book 1. Stockholm, June 12-16, 1988:273.

 4. Chiasson MA, Stoneburner RL, Telzak E, Hildebrandt D, Schultz S, Jaffe HW.
Risk  factors for HIV-1 infection in STD clinic patients:  evidence for crack-
related heterosexual transmission (Abstract).  V International  Conference  on
AIDS. Montreal, June 4-9, 1989:117.

 5.  Quinn  TC,  Glasser  D,  Cannon RO,  et al.  Human immunodeficiency virus
infection among patients attending clinics for sexually transmitted  diseases.
N Engl J Med 1988;318:197-203.

 6.  Judson F,  Cohn D, Douglas J.  HIV seroprevalence in heterosexual men and
women,  Denver  Metro  STD  Clinic,  1985-1988  (Abstract).   V  International
Conference on AIDS. Montreal, June 4-9, 1989:87.

 7.  Stoneburner  RL,  Chiasson MA,  Solomon K,  Rosenthal S.  Risk factors in
military  recruits  positive  for  HIV  antibody  (Letter).   N  Engl  J   Med
1986;315:1355.

 8. Dillon BA, Spencer N. Follow-up counseling and risk behavior assessment of
HIV   antibody  positive  military  recruits  (Abstract).   III  International
Conference on AIDS. Washington, DC, June 1-5, 1987:42.

 9.  Peterson L and the HIV Blood Donor Study Group.  Surveillance for unusual
modes  of  HIV  transmission  in  the USA--a 5-year multicenter study of blood
donors (Abstract).  V International Conference on AIDS.  Montreal,  June  4-9,

Health InfoCom Network News                                             Page 22
Volume  2, Number 26                                            June 26, 1989

1989:83.

10.  Peterman  TA,  Curran  JW.  Sexual transmission of human immunodeficiency
virus. JAMA 1986;256:2222-6.

11.  Holmes KK, Kreiss J.  Heterosexual transmission of human immunodeficiency
virus: overview of a neglected aspect of the AIDS epidemic.  J Acquired Immune
Deficiency Syndromes 1988;1:602-10.

12.  Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR.  Cocaine
use  and  HIV  infection  in  intravenous  drug  users in San Francisco.  JAMA
1989;261:561-5.

13.  Castro KG, Lifson AR,  White CR,  et al.  Investigations of AIDS patients
with no previously identified risk factors. JAMA 1988;259:1338-42.

14. Dondero TJ, Jr, Pappaioanou M, Curran JW. Monitoring the levels and trends
of HIV infection: the Public Health Service's HIV surveillance program. Public
Health Rep 1988;103:213-20.

15.  CDC.  Continuing  increase  in  infectious syphilis--United States.  MMWR
1988;37:35-8.

16.  CDC.  Relationship of syphilis to drug use and  prostitution--Connecticut
and Philadelphia, Pennsylvania. MMWR 1988;37:755-8,764.

17.  CDC.  Additional  recommendations to reduce sexual and drug abuse-related
transmission of human T-lymphotropic virus type III/lymphadenopathy-associated
virus. MMWR 1986;35:152-5.

18. CDC.  Public Health Service guidelines for counseling and antibody testing
to prevent HIV infection and AIDS. MMWR 1987;36:509-15,521-2.

                                     #####

                               Notice to Readers
                       MMWR Recommendations and Reports

    A  new  component in the MMWR series of publications,  Recommendations and
Reports,  has been developed.  The purposes of this publication are to  permit
increased access to recommendations and guidelines by consolidating them under
one  cover  and  to  accommodate other reports more lengthy than articles that
typically appear in the weekly MMWR.  The first issue of  Recommendations  and
Reports,  published June 16, 1989, contains guidelines for prophylaxis against
Pnemocystis carinii pneumonia(1).  Subscribers to the MMWR  will  receive  the
Recommendations and Reports.

Reference

1.  CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for
persons infected with human immunodeficiency virus. MMWR 1989;38 (S-5).

Health InfoCom Network News                                             Page 23

--- end part 3 of 3 cut here ---